Impact of measurable residual disease by decentralized flow cytometry: a PETHEMA real-world study in 1076 patients with acute myeloid leukemia
暂无分享，去创建一个
E. Colado | M. González-Díaz | A. Órfão | M. Sanz | M. Barrios | B. Paiva | J. S. San Miguel | J. Pérez-Simón | C. Sossa | M. Vidriales | A. Sempere | M. Cedena | J. Martínez-López | J. Serrano | J. Pérez-Oteyza | T. Caballero-Velázquez | P. Montesinos | M. Sayas | D. Martínez-Cuadrón | J. Garcés | M. Amigo | T. Bernal | Joaquín Sánchez | L. Cordón | S. Grille | C. Rodríguez-Medina | F. Tarín | R. García-Boyero | M. Pérez-Encinas | C. Benavente | M. Colorado | C. Botella | L. Algarra | Olga Pérez | C. Simoes | J. Alonso‐Dominguez | Lisette Costilla-Barriga | Catia Simoes | Lorenzo Algarra | J. Martínez‐López